BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home » Authors » Larry Haimovitch

Larry Haimovitch

Articles

ARTICLES

New Horizons Glaucoma Forum: MIGS seen as the 'new sexy' in the glaucoma device world

Feb. 7, 2013
By Larry Haimovitch

J.P. Morgan Healthcare Conference: Private ophthalmic companies make pitches to audience

Jan. 15, 2013
By Larry Haimovitch
SAN FRANCISCO — Private companies continued to be of great interest at this conference and one of the most keenly anticipated presentations was from Bausch + Lomb (B + L; Rochester, New York). B + L, which was founded in 1853, is one of the oldest continuous operating companies in the U.S. and has one of the best-known healthcare brands in the world.
Read More

Lasik procedures head up discussions at AAO meeting

Nov. 19, 2012
By Larry Haimovitch
CHICAGO — The annual meeting of the American Academy of Ophthalmology (AAO; San Francisco), the largest ophthalmic meeting of the year, took place here in the past few days, with an estimated 26,000 persons from around the world in attendance. The meeting was conducted in conjunction with the Asia-Pacific Academy of Ophthalmology.
Read More

TCT 2012: PFO clinical trial results: more questions than answers

Oct. 30, 2012
By Larry Haimovitch

Aesthetics market earns its close-up at Canaccord conference

Aug. 22, 2012
By Larry Haimovitch

Wilson Sonsini conference: Meeting focuses on capital investment for med-tech

June 27, 2012
By Larry Haimovitch

HRS 2012: New AF mapping technology data may finally silence the skeptics

May 15, 2012
By Larry Haimovitch

Conference's 'vision' allows industry leaders second sight

April 27, 2012
By Larry Haimovitch

Society of Interventional Radiology: Meeting spotlights future patient care improvements

April 3, 2012
By Larry Haimovitch
SAN FRANCISCO The 37th annual meeting of the Society of Interventional Radiology (Fairfax, Virginia) took place here last week and showcased several technologies and procedures which show promise to improve patient care and become important contributors in the future.
Read More

Glaucoma New Horizons Forum: Glaucoma forum seeks to prevent the notorious 'silent thief of sight'

Feb. 8, 2012
By Larry Haimovitch
View All Articles by Larry Haimovitch

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2026.
  • Liver disease

    FB-7033 demonstrates efficacy in MASH management

    BioWorld Science
    17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
  • Illustration of antibody carrying radioactive isotope

    Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC

    BioWorld Science
    At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
  • Bial-Portela discovers new OX1 receptor antagonists

    BioWorld Science
    Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
  • Dividing cancer cells in the cross hairs

    SKL-35501 shows broad antitumor activity in solid tumors

    BioWorld Science
    Neurotensin receptor 1 (NTSR1) is overexpressed in several aggressive solid tumors, including colorectal and pancreatic cancer, making it a promising therapeutic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing